| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine N-sulfotransferase activity | 1.14e-05 | 4 | 28 | 2 | GO:0015016 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine deacetylase activity | 1.14e-05 | 4 | 28 | 2 | GO:0050119 | |
| GeneOntologyMolecularFunction | ubiquitin conjugating enzyme activity | 1.86e-05 | 37 | 28 | 3 | GO:0061631 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein conjugating enzyme activity | 2.93e-05 | 43 | 28 | 3 | GO:0061650 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 9.49e-05 | 337 | 28 | 5 | GO:0031625 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase binding | 1.26e-04 | 358 | 28 | 5 | GO:0044389 | |
| GeneOntologyMolecularFunction | heparan sulfate sulfotransferase activity | 1.97e-04 | 15 | 28 | 2 | GO:0034483 | |
| GeneOntologyMolecularFunction | diacylglycerol-dependent serine/threonine kinase activity | 2.25e-04 | 16 | 28 | 2 | GO:0004697 | |
| GeneOntologyMolecularFunction | deacetylase activity | 1.43e-03 | 40 | 28 | 2 | GO:0019213 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 2.69e-03 | 55 | 28 | 2 | GO:0008146 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 2.77e-03 | 709 | 28 | 5 | GO:0016773 | |
| GeneOntologyMolecularFunction | kinase activity | 3.82e-03 | 764 | 28 | 5 | GO:0016301 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 4.81e-03 | 74 | 28 | 2 | GO:0016782 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides | 5.74e-03 | 81 | 28 | 2 | GO:0016811 | |
| GeneOntologyBiologicalProcess | protein K29-linked ubiquitination | 6.35e-07 | 13 | 28 | 3 | GO:0035519 | |
| GeneOntologyBiologicalProcess | protein K27-linked ubiquitination | 8.07e-07 | 14 | 28 | 3 | GO:0044314 | |
| GeneOntologyBiologicalProcess | protein K6-linked ubiquitination | 1.50e-06 | 17 | 28 | 3 | GO:0085020 | |
| GeneOntologyBiologicalProcess | protein K11-linked ubiquitination | 1.69e-05 | 37 | 28 | 3 | GO:0070979 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 4.95e-05 | 8 | 28 | 2 | GO:0015014 | |
| GeneOntologyBiologicalProcess | heparin biosynthetic process | 9.70e-05 | 11 | 28 | 2 | GO:0030210 | |
| GeneOntologyBiologicalProcess | protein K63-linked ubiquitination | 1.47e-04 | 76 | 28 | 3 | GO:0070534 | |
| GeneOntologyBiologicalProcess | heparin metabolic process | 2.39e-04 | 17 | 28 | 2 | GO:0030202 | |
| GeneOntologyBiologicalProcess | protein K48-linked ubiquitination | 3.32e-04 | 100 | 28 | 3 | GO:0070936 | |
| HumanPheno | Psychic epileptic aura | 5.18e-05 | 10 | 6 | 2 | HP:0033346 | |
| HumanPheno | Experiential epileptic aura | 5.18e-05 | 10 | 6 | 2 | HP:0012002 | |
| HumanPheno | Focal autonomic seizure | 6.33e-05 | 11 | 6 | 2 | HP:0011154 | |
| HumanPheno | Focal sensory seizure | 2.64e-04 | 22 | 6 | 2 | HP:0011157 | |
| HumanPheno | Abnormal autonomic nervous system physiology | 3.07e-04 | 130 | 6 | 3 | HP:0012332 | |
| HumanPheno | Epileptic aura | 3.43e-04 | 25 | 6 | 2 | HP:0033348 | |
| Domain | UBQ-conjugating_AS | 6.07e-06 | 25 | 27 | 3 | IPR023313 | |
| Domain | HSNSD | 1.21e-05 | 4 | 27 | 2 | PF12062 | |
| Domain | Heparan_SO4_deacetylase | 1.21e-05 | 4 | 27 | 2 | IPR021930 | |
| Domain | UQ_con | 2.38e-05 | 39 | 27 | 3 | PF00179 | |
| Domain | UBIQUITIN_CONJUGAT_1 | 2.57e-05 | 40 | 27 | 3 | PS00183 | |
| Domain | UBIQUITIN_CONJUGAT_2 | 2.77e-05 | 41 | 27 | 3 | PS50127 | |
| Domain | UBQ-conjugat_E2 | 2.77e-05 | 41 | 27 | 3 | IPR000608 | |
| Domain | - | 5.36e-05 | 51 | 27 | 3 | 3.10.110.10 | |
| Domain | UBQ-conjugating_enzyme/RWD | 6.01e-05 | 53 | 27 | 3 | IPR016135 | |
| Domain | Kinase-like_dom | 1.02e-04 | 542 | 27 | 6 | IPR011009 | |
| Domain | DAG/PE-bd | 4.16e-04 | 21 | 27 | 2 | IPR020454 | |
| Domain | Sulfotransferase_dom | 1.23e-03 | 36 | 27 | 2 | IPR000863 | |
| Domain | Sulfotransfer_1 | 1.23e-03 | 36 | 27 | 2 | PF00685 | |
| Domain | C1_1 | 3.06e-03 | 57 | 27 | 2 | PF00130 | |
| Domain | ZF_DAG_PE_1 | 3.84e-03 | 64 | 27 | 2 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 3.84e-03 | 64 | 27 | 2 | PS50081 | |
| Domain | C1 | 3.96e-03 | 65 | 27 | 2 | SM00109 | |
| Domain | PROTEIN_KINASE_ATP | 4.04e-03 | 459 | 27 | 4 | PS00107 | |
| Domain | PE/DAG-bd | 4.08e-03 | 66 | 27 | 2 | IPR002219 | |
| Domain | Prot_kinase_dom | 5.05e-03 | 489 | 27 | 4 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 5.20e-03 | 493 | 27 | 4 | PS50011 | |
| Domain | Ser/Thr_kinase_AS | 1.44e-02 | 357 | 27 | 3 | IPR008271 | |
| Domain | S_TKc | 1.46e-02 | 359 | 27 | 3 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 1.50e-02 | 362 | 27 | 3 | PS00108 | |
| Domain | Protein_kinase_ATP_BS | 1.69e-02 | 379 | 27 | 3 | IPR017441 | |
| Domain | Pkinase | 1.71e-02 | 381 | 27 | 3 | PF00069 | |
| Domain | C2 | 1.78e-02 | 142 | 27 | 2 | PS50004 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_BIOSYNTHESIS | 1.15e-04 | 11 | 21 | 2 | M47921 | |
| Pathway | WP_GLIOBLASTOMA_SIGNALING | 2.42e-04 | 83 | 21 | 3 | M39637 | |
| Pathway | REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING | 3.19e-04 | 18 | 21 | 2 | MM15680 | |
| Pathway | REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT | 3.56e-04 | 19 | 21 | 2 | M27020 | |
| Pathway | REACTOME_SIGNALING_BY_CSF3_G_CSF | 4.80e-04 | 22 | 21 | 2 | MM15675 | |
| Pathway | REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1 | 5.25e-04 | 23 | 21 | 2 | M1003 | |
| Pathway | REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING | 6.21e-04 | 25 | 21 | 2 | M41829 | |
| Pathway | REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1 | 6.21e-04 | 25 | 21 | 2 | MM15646 | |
| Pathway | KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE | 6.72e-04 | 26 | 21 | 2 | M7330 | |
| Pathway | REACTOME_HS_GAG_BIOSYNTHESIS | 8.38e-04 | 29 | 21 | 2 | MM14802 | |
| Pathway | REACTOME_SIGNALING_BY_CSF3_G_CSF | 8.97e-04 | 30 | 21 | 2 | M41825 | |
| Pathway | REACTOME_HS_GAG_BIOSYNTHESIS | 9.58e-04 | 31 | 21 | 2 | M685 | |
| Pathway | KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS | 1.01e-03 | 135 | 21 | 3 | M15247 | |
| Pathway | REACTOME_PINK1_PRKN_MEDIATED_MITOPHAGY | 1.02e-03 | 32 | 21 | 2 | M27419 | |
| Pathway | REACTOME_PINK1_PRKN_MEDIATED_MITOPHAGY | 1.15e-03 | 34 | 21 | 2 | MM15167 | |
| Pathway | REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING | 1.22e-03 | 35 | 21 | 2 | M985 | |
| Pathway | REACTOME_MITOPHAGY | 1.52e-03 | 39 | 21 | 2 | M27418 | |
| Pathway | PID_ERBB1_INTERNALIZATION_PATHWAY | 1.67e-03 | 41 | 21 | 2 | M214 | |
| Pathway | REACTOME_MITOPHAGY | 1.67e-03 | 41 | 21 | 2 | MM15166 | |
| Pathway | WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS | 1.67e-03 | 41 | 21 | 2 | M48095 | |
| Pathway | REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS | 2.01e-03 | 45 | 21 | 2 | MM15508 | |
| Pathway | REACTOME_REGULATION_OF_TNFR1_SIGNALING | 2.19e-03 | 47 | 21 | 2 | MM15179 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 2.89e-03 | 54 | 21 | 2 | MM14633 | |
| Pathway | REACTOME_TNF_SIGNALING | 3.10e-03 | 56 | 21 | 2 | MM15453 | |
| Pathway | WP_PROTEASOME_DEGRADATION | 3.10e-03 | 56 | 21 | 2 | MM15901 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 3.21e-03 | 57 | 21 | 2 | M692 | |
| Pathway | REACTOME_TNF_SIGNALING | 3.21e-03 | 57 | 21 | 2 | M27713 | |
| Pathway | REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS | 3.44e-03 | 59 | 21 | 2 | M27763 | |
| Pathway | WP_PROTEASOME_DEGRADATION | 3.79e-03 | 62 | 21 | 2 | M39639 | |
| Pathway | REACTOME_PEROXISOMAL_PROTEIN_IMPORT | 3.91e-03 | 63 | 21 | 2 | M27915 | |
| Pathway | REACTOME_PROTEIN_UBIQUITINATION | 4.15e-03 | 65 | 21 | 2 | MM15490 | |
| Pathway | REACTOME_PEROXISOMAL_PROTEIN_IMPORT | 4.15e-03 | 65 | 21 | 2 | MM15628 | |
| Pubmed | The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor. | 1.63e-08 | 7 | 28 | 3 | 21685362 | |
| Pubmed | 1.63e-08 | 7 | 28 | 3 | 30884854 | ||
| Pubmed | Structure and catalytic activation of the TRIM23 RING E3 ubiquitin ligase. | 2.61e-08 | 8 | 28 | 3 | 28681414 | |
| Pubmed | Ube2W conjugates ubiquitin to α-amino groups of protein N-termini. | 2.61e-08 | 8 | 28 | 3 | 23560854 | |
| Pubmed | 2.61e-08 | 8 | 28 | 3 | 29323787 | ||
| Pubmed | 5.59e-08 | 10 | 28 | 3 | 31087003 | ||
| Pubmed | 5.59e-08 | 10 | 28 | 3 | 28757353 | ||
| Pubmed | The UbL protein UBTD1 stably interacts with the UBE2D family of E2 ubiquitin conjugating enzymes. | 1.02e-07 | 12 | 28 | 3 | 24211586 | |
| Pubmed | Ubiquitination of STING at lysine 224 controls IRF3 activation. | 1.33e-07 | 13 | 28 | 3 | 28763789 | |
| Pubmed | 1.69e-07 | 14 | 28 | 3 | 36481767 | ||
| Pubmed | 3.15e-07 | 17 | 28 | 3 | 33650289 | ||
| Pubmed | 3.15e-07 | 17 | 28 | 3 | 36563856 | ||
| Pubmed | 4.49e-07 | 19 | 28 | 3 | 27425610 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 26912277 | ||
| Pubmed | The MALDI-TOF E2/E3 Ligase Assay as Universal Tool for Drug Discovery in the Ubiquitin Pathway. | 8.19e-07 | 23 | 28 | 3 | 30017913 | |
| Pubmed | 9.35e-07 | 24 | 28 | 3 | 24647965 | ||
| Pubmed | Reconstitution of human CMG helicase ubiquitylation by CUL2LRR1 and multiple E2 enzymes. | 9.35e-07 | 24 | 28 | 3 | 34195792 | |
| Pubmed | The E2 ubiquitin-conjugating enzymes direct polyubiquitination to preferred lysines. | 1.20e-06 | 26 | 28 | 3 | 20061386 | |
| Pubmed | Functional interactions between ubiquitin E2 enzymes and TRIM proteins. | 1.35e-06 | 27 | 28 | 3 | 21143188 | |
| Pubmed | Real-time tracking of complex ubiquitination cascades using a fluorescent confocal on-bead assay. | 1.35e-06 | 27 | 28 | 3 | 30097011 | |
| Pubmed | Structural and functional characterization of hMEX-3C Ring finger domain as an E3 ubiquitin ligase. | 1.87e-06 | 3 | 28 | 2 | 30095198 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 11912157 | ||
| Pubmed | Identification of a family of closely related human ubiquitin conjugating enzymes. | 1.87e-06 | 3 | 28 | 2 | 8530467 | |
| Pubmed | 3.56e-06 | 37 | 28 | 3 | 19430480 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 22049073 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 9535861 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 20696396 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 12070138 | ||
| Pubmed | Physical and functional interactions between ZIP kinase and UbcH5. | 3.75e-06 | 4 | 28 | 2 | 18515077 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 31241013 | ||
| Pubmed | Protein kinase Cδ mediates the activation of protein kinase D2 in platelets. | 3.75e-06 | 4 | 28 | 2 | 21736870 | |
| Pubmed | 3.87e-06 | 38 | 28 | 3 | 35331737 | ||
| Pubmed | Activity-enhancing mutations in an E3 ubiquitin ligase identified by high-throughput mutagenesis. | 6.24e-06 | 5 | 28 | 2 | 23509263 | |
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 10329681 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 16413270 | ||
| Pubmed | Allosteric activation of the RNF146 ubiquitin ligase by a poly(ADP-ribosyl)ation signal. | 6.24e-06 | 5 | 28 | 2 | 25327252 | |
| Pubmed | The RING-H2 protein RNF11 is overexpressed in breast cancer and is a target of Smurf2 E3 ligase. | 6.24e-06 | 5 | 28 | 2 | 14562029 | |
| Pubmed | E3 ubiquitin ligase activity of the trifunctional ARD1 (ADP-ribosylation factor domain protein 1). | 6.24e-06 | 5 | 28 | 2 | 15684077 | |
| Pubmed | Systematic E2 screening reveals a UBE2D-RNF138-CtIP axis promoting DNA repair. | 6.24e-06 | 5 | 28 | 2 | 26502057 | |
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 23408431 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 31929179 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 11087757 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 18313049 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 19741096 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 8090726 | ||
| Pubmed | 9.36e-06 | 6 | 28 | 2 | 9990509 | ||
| Pubmed | Role of E2-RING Interactions in Governing RNF4-Mediated Substrate Ubiquitination. | 9.36e-06 | 6 | 28 | 2 | 27678051 | |
| Pubmed | Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in vivo. | 9.36e-06 | 6 | 28 | 2 | 15280377 | |
| Pubmed | Negative regulation of the RLH signaling by the E3 ubiquitin ligase RNF114. | 9.36e-06 | 6 | 28 | 2 | 28625874 | |
| Pubmed | h-Goliath, paralog of GRAIL, is a new E3 ligase protein, expressed in human leukocytes. | 9.36e-06 | 6 | 28 | 2 | 16549277 | |
| Pubmed | The E3 ubiquitin ligase TRIM32 regulates myoblast proliferation by controlling turnover of NDRG2. | 9.36e-06 | 6 | 28 | 2 | 25701873 | |
| Pubmed | Trim17-mediated ubiquitination and degradation of Mcl-1 initiate apoptosis in neurons. | 9.36e-06 | 6 | 28 | 2 | 22976837 | |
| Pubmed | 9.36e-06 | 6 | 28 | 2 | 33962630 | ||
| Pubmed | Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1. | 9.36e-06 | 6 | 28 | 2 | 22124327 | |
| Pubmed | 9.36e-06 | 6 | 28 | 2 | 30404641 | ||
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 11714696 | ||
| Pubmed | RNF122: a novel ubiquitin ligase associated with calcium-modulating cyclophilin ligand. | 1.31e-05 | 7 | 28 | 2 | 20553626 | |
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 20051513 | ||
| Pubmed | A ubiquitin ligase complex assembles linear polyubiquitin chains. | 1.31e-05 | 7 | 28 | 2 | 17006537 | |
| Pubmed | The E3 ubiquitin ligase MID1 catalyzes ubiquitination and cleavage of Fu. | 1.31e-05 | 7 | 28 | 2 | 25278022 | |
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 28322253 | ||
| Pubmed | Measuring rates of ubiquitin chain formation as a functional readout of ligase activity. | 1.31e-05 | 7 | 28 | 2 | 22350887 | |
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 34057440 | ||
| Pubmed | Priming and extending: a UbcH5/Cdc34 E2 handoff mechanism for polyubiquitination on a SCF substrate. | 1.31e-05 | 7 | 28 | 2 | 20347421 | |
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 22613722 | ||
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 21068390 | ||
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 24831002 | ||
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 17719635 | ||
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 33282879 | ||
| Pubmed | 1.74e-05 | 8 | 28 | 2 | 25207814 | ||
| Pubmed | E2~Ub conjugates regulate the kinase activity of Shigella effector OspG during pathogenesis. | 1.74e-05 | 8 | 28 | 2 | 24446487 | |
| Pubmed | Involvement of Rabring7 in EGF receptor degradation as an E3 ligase. | 1.74e-05 | 8 | 28 | 2 | 17462600 | |
| Pubmed | A novel route for F-box protein-mediated ubiquitination links CHIP to glycoprotein quality control. | 1.74e-05 | 8 | 28 | 2 | 16682404 | |
| Pubmed | Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation. | 1.74e-05 | 8 | 28 | 2 | 14661060 | |
| Pubmed | 1.74e-05 | 8 | 28 | 2 | 12670957 | ||
| Pubmed | Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53. | 1.74e-05 | 8 | 28 | 2 | 15247280 | |
| Pubmed | 1.74e-05 | 8 | 28 | 2 | 28972136 | ||
| Pubmed | FGF signaling sustains the odontogenic fate of dental mesenchyme by suppressing β-catenin signaling. | 1.74e-05 | 8 | 28 | 2 | 24067353 | |
| Pubmed | 1.74e-05 | 8 | 28 | 2 | 18838541 | ||
| Pubmed | Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO. | 2.24e-05 | 9 | 28 | 2 | 12525502 | |
| Pubmed | Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. | 2.24e-05 | 9 | 28 | 2 | 17460044 | |
| Pubmed | Comparison of Cross-Regulation by Different OTUB1:E2 Complexes. | 2.24e-05 | 9 | 28 | 2 | 32049508 | |
| Pubmed | TRAF-interacting protein (TRIP) is a RING-dependent ubiquitin ligase. | 2.24e-05 | 9 | 28 | 2 | 17544371 | |
| Pubmed | 2.24e-05 | 9 | 28 | 2 | 26711259 | ||
| Pubmed | Bag1 directly routes immature BCR-ABL for proteasomal degradation. | 2.80e-05 | 10 | 28 | 2 | 20675402 | |
| Pubmed | 2.80e-05 | 10 | 28 | 2 | 33607208 | ||
| Pubmed | E2 conjugating enzyme selectivity and requirements for function of the E3 ubiquitin ligase CHIP. | 2.80e-05 | 10 | 28 | 2 | 21518764 | |
| Pubmed | 2.80e-05 | 10 | 28 | 2 | 37345264 | ||
| Pubmed | A dimer-monomer switch controls CHIP-dependent substrate ubiquitylation and processing. | 3.42e-05 | 11 | 28 | 2 | 36027913 | |
| Pubmed | 3.42e-05 | 11 | 28 | 2 | 24438103 | ||
| Pubmed | 3.42e-05 | 11 | 28 | 2 | 19712108 | ||
| Pubmed | Developmental and regional expression of heparan sulfate sulfotransferase genes in the mouse brain. | 3.42e-05 | 11 | 28 | 2 | 15944372 | |
| Pubmed | 3.42e-05 | 11 | 28 | 2 | 22334663 | ||
| Pubmed | 3.82e-05 | 81 | 28 | 3 | 39217171 | ||
| Pubmed | E1-E2 interactions in ubiquitin and Nedd8 ligation pathways. | 4.10e-05 | 12 | 28 | 2 | 22069333 | |
| Pubmed | 4.10e-05 | 12 | 28 | 2 | 12460940 | ||
| Pubmed | 4.10e-05 | 12 | 28 | 2 | 24905733 | ||
| Pubmed | 4.85e-05 | 13 | 28 | 2 | 31120930 | ||
| Pubmed | 4.85e-05 | 13 | 28 | 2 | 36576150 | ||
| Pubmed | Arkadia, a novel SUMO-targeted ubiquitin ligase involved in PML degradation. | 4.85e-05 | 13 | 28 | 2 | 23530056 | |
| Interaction | DTX1 interactions | 1.51e-07 | 35 | 28 | 4 | int:DTX1 | |
| Interaction | ARK2C interactions | 5.24e-07 | 12 | 28 | 3 | int:ARK2C | |
| Interaction | TRIM43 interactions | 8.33e-07 | 53 | 28 | 4 | int:TRIM43 | |
| Interaction | RNF26 interactions | 1.38e-06 | 60 | 28 | 4 | int:RNF26 | |
| Interaction | RNF150 interactions | 2.70e-06 | 20 | 28 | 3 | int:RNF150 | |
| Interaction | UBOX5 interactions | 4.18e-06 | 23 | 28 | 3 | int:UBOX5 | |
| Interaction | RFFL interactions | 5.08e-06 | 83 | 28 | 4 | int:RFFL | |
| Interaction | RNF103 interactions | 8.57e-06 | 29 | 28 | 3 | int:RNF103 | |
| Interaction | CADPS2 interactions | 9.51e-06 | 30 | 28 | 3 | int:CADPS2 | |
| Interaction | TRIM62 interactions | 1.16e-05 | 32 | 28 | 3 | int:TRIM62 | |
| Interaction | BIRC8 interactions | 1.16e-05 | 32 | 28 | 3 | int:BIRC8 | |
| Interaction | TRIM45 interactions | 1.27e-05 | 33 | 28 | 3 | int:TRIM45 | |
| Interaction | TRIM17 interactions | 1.40e-05 | 34 | 28 | 3 | int:TRIM17 | |
| Interaction | ZNRF1 interactions | 1.66e-05 | 36 | 28 | 3 | int:ZNRF1 | |
| Interaction | UVSSA interactions | 1.81e-05 | 37 | 28 | 3 | int:UVSSA | |
| Interaction | UBTD1 interactions | 2.29e-05 | 40 | 28 | 3 | int:UBTD1 | |
| Interaction | RNF25 interactions | 2.86e-05 | 43 | 28 | 3 | int:RNF25 | |
| Interaction | MARCHF3 interactions | 2.86e-05 | 43 | 28 | 3 | int:MARCHF3 | |
| Interaction | TRIM38 interactions | 3.74e-05 | 47 | 28 | 3 | int:TRIM38 | |
| Interaction | ZNRF2 interactions | 3.74e-05 | 47 | 28 | 3 | int:ZNRF2 | |
| Interaction | TRIM10 interactions | 3.98e-05 | 48 | 28 | 3 | int:TRIM10 | |
| Interaction | BFAR interactions | 3.98e-05 | 48 | 28 | 3 | int:BFAR | |
| Interaction | TRIM50 interactions | 4.24e-05 | 49 | 28 | 3 | int:TRIM50 | |
| Interaction | RNF14 interactions | 4.24e-05 | 49 | 28 | 3 | int:RNF14 | |
| Interaction | RMND5B interactions | 4.24e-05 | 49 | 28 | 3 | int:RMND5B | |
| Interaction | RNF216 interactions | 5.07e-05 | 52 | 28 | 3 | int:RNF216 | |
| Interaction | RNF125 interactions | 5.37e-05 | 53 | 28 | 3 | int:RNF125 | |
| Interaction | TRIM2 interactions | 5.37e-05 | 53 | 28 | 3 | int:TRIM2 | |
| Interaction | RNF167 interactions | 5.68e-05 | 54 | 28 | 3 | int:RNF167 | |
| Interaction | MYLIP interactions | 6.34e-05 | 56 | 28 | 3 | int:MYLIP | |
| Interaction | NDST3 interactions | 6.66e-05 | 9 | 28 | 2 | int:NDST3 | |
| Interaction | RNF13 interactions | 7.79e-05 | 60 | 28 | 3 | int:RNF13 | |
| Interaction | CHFR interactions | 7.79e-05 | 60 | 28 | 3 | int:CHFR | |
| Interaction | PELI1 interactions | 9.90e-05 | 65 | 28 | 3 | int:PELI1 | |
| Interaction | CNOT4 interactions | 9.90e-05 | 65 | 28 | 3 | int:CNOT4 | |
| Interaction | DTX3L interactions | 1.13e-04 | 68 | 28 | 3 | int:DTX3L | |
| Interaction | ITCH interactions | 1.18e-04 | 356 | 28 | 5 | int:ITCH | |
| Interaction | SLC31A1 interactions | 1.37e-04 | 192 | 28 | 4 | int:SLC31A1 | |
| Interaction | UBA1 interactions | 1.60e-04 | 380 | 28 | 5 | int:UBA1 | |
| Interaction | UHRF2 interactions | 1.60e-04 | 200 | 28 | 4 | int:UHRF2 | |
| Interaction | F12 interactions | 1.64e-04 | 77 | 28 | 3 | int:F12 | |
| Interaction | TRIM3 interactions | 1.84e-04 | 80 | 28 | 3 | int:TRIM3 | |
| Interaction | RFWD3 interactions | 1.84e-04 | 80 | 28 | 3 | int:RFWD3 | |
| Interaction | RNF122 interactions | 2.21e-04 | 16 | 28 | 2 | int:RNF122 | |
| Interaction | SQSTM1 interactions | 2.26e-04 | 1257 | 28 | 8 | int:SQSTM1 | |
| Interaction | RNF10 interactions | 2.35e-04 | 87 | 28 | 3 | int:RNF10 | |
| Interaction | LRSAM1 interactions | 2.44e-04 | 88 | 28 | 3 | int:LRSAM1 | |
| Interaction | MGRN1 interactions | 2.60e-04 | 90 | 28 | 3 | int:MGRN1 | |
| Interaction | RNF114 interactions | 2.69e-04 | 91 | 28 | 3 | int:RNF114 | |
| Interaction | RNF166 interactions | 2.69e-04 | 91 | 28 | 3 | int:RNF166 | |
| Interaction | TRIM5 interactions | 2.69e-04 | 91 | 28 | 3 | int:TRIM5 | |
| Interaction | TOPORS interactions | 3.15e-04 | 96 | 28 | 3 | int:TOPORS | |
| Interaction | RNF111 interactions | 3.24e-04 | 97 | 28 | 3 | int:RNF111 | |
| Interaction | TRIM8 interactions | 3.55e-04 | 100 | 28 | 3 | int:TRIM8 | |
| Interaction | MUL1 interactions | 3.65e-04 | 101 | 28 | 3 | int:MUL1 | |
| Interaction | RNF38 interactions | 3.76e-04 | 102 | 28 | 3 | int:RNF38 | |
| Interaction | TRIM35 interactions | 3.87e-04 | 103 | 28 | 3 | int:TRIM35 | |
| Interaction | TRIM39 interactions | 4.45e-04 | 108 | 28 | 3 | int:TRIM39 | |
| Interaction | DTX3 interactions | 4.45e-04 | 108 | 28 | 3 | int:DTX3 | |
| Interaction | UBE4A interactions | 4.57e-04 | 109 | 28 | 3 | int:UBE4A | |
| Interaction | ZNRF4 interactions | 4.69e-04 | 110 | 28 | 3 | int:ZNRF4 | |
| Interaction | MID2 interactions | 4.80e-04 | 267 | 28 | 4 | int:MID2 | |
| Interaction | UFM1 interactions | 5.62e-04 | 117 | 28 | 3 | int:UFM1 | |
| Interaction | MID1 interactions | 5.90e-04 | 119 | 28 | 3 | int:MID1 | |
| Interaction | POLM interactions | 5.93e-04 | 26 | 28 | 2 | int:POLM | |
| Interaction | AREL1 interactions | 6.39e-04 | 27 | 28 | 2 | int:AREL1 | |
| Interaction | RNF5 interactions | 6.97e-04 | 126 | 28 | 3 | int:RNF5 | |
| Interaction | PHF7 interactions | 7.90e-04 | 30 | 28 | 2 | int:PHF7 | |
| Interaction | RNF115 interactions | 8.34e-04 | 134 | 28 | 3 | int:RNF115 | |
| Interaction | WSB1 interactions | 8.44e-04 | 31 | 28 | 2 | int:WSB1 | |
| Interaction | RNF126 interactions | 9.08e-04 | 138 | 28 | 3 | int:RNF126 | |
| Interaction | NEDD4L interactions | 9.45e-04 | 320 | 28 | 4 | int:NEDD4L | |
| Interaction | NDST1 interactions | 1.02e-03 | 34 | 28 | 2 | int:NDST1 | |
| Interaction | DTX2 interactions | 1.06e-03 | 330 | 28 | 4 | int:DTX2 | |
| Interaction | UBE2K interactions | 1.13e-03 | 149 | 28 | 3 | int:UBE2K | |
| Interaction | RNF7 interactions | 1.16e-03 | 150 | 28 | 3 | int:RNF7 | |
| Interaction | HECW1 interactions | 1.20e-03 | 37 | 28 | 2 | int:HECW1 | |
| Interaction | PJA2 interactions | 1.25e-03 | 154 | 28 | 3 | int:PJA2 | |
| Interaction | VLDLR interactions | 1.34e-03 | 39 | 28 | 2 | int:VLDLR | |
| Interaction | RNF185 interactions | 1.34e-03 | 158 | 28 | 3 | int:RNF185 | |
| Interaction | RNF181 interactions | 1.39e-03 | 160 | 28 | 3 | int:RNF181 | |
| Interaction | MAP3K1 interactions | 1.42e-03 | 161 | 28 | 3 | int:MAP3K1 | |
| Interaction | NSMCE1 interactions | 1.55e-03 | 42 | 28 | 2 | int:NSMCE1 | |
| Interaction | RNF220 interactions | 1.55e-03 | 42 | 28 | 2 | int:RNF220 | |
| Interaction | RNF11 interactions | 1.63e-03 | 169 | 28 | 3 | int:RNF11 | |
| Interaction | LNX1 interactions | 1.63e-03 | 634 | 28 | 5 | int:LNX1 | |
| Interaction | RBCK1 interactions | 1.83e-03 | 176 | 28 | 3 | int:RBCK1 | |
| Interaction | PRSS50 interactions | 1.86e-03 | 46 | 28 | 2 | int:PRSS50 | |
| Interaction | FBXO4 interactions | 1.86e-03 | 46 | 28 | 2 | int:FBXO4 | |
| Interaction | TMA7 interactions | 1.86e-03 | 46 | 28 | 2 | int:TMA7 | |
| Interaction | MDM2 interactions | 1.92e-03 | 658 | 28 | 5 | int:MDM2 | |
| Interaction | DUSP14 interactions | 1.98e-03 | 181 | 28 | 3 | int:DUSP14 | |
| Interaction | DZIP3 interactions | 2.04e-03 | 183 | 28 | 3 | int:DZIP3 | |
| Cytoband | 12p12 | 2.79e-05 | 13 | 28 | 2 | 12p12 | |
| GeneFamily | Ubiquitin conjugating enzymes E2 | 1.62e-05 | 41 | 22 | 3 | 102 | |
| GeneFamily | Sulfotransferases, membrane bound | 9.17e-04 | 37 | 22 | 2 | 763 | |
| GeneFamily | Immunoglobulin like domain containing | 2.28e-02 | 193 | 22 | 2 | 594 | |
| Coexpression | KRAS.300_UP.V1_UP | 1.57e-05 | 143 | 28 | 4 | M2875 | |
| Coexpression | GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_UP | 5.61e-05 | 198 | 28 | 4 | M7200 | |
| Coexpression | GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_UP | 5.72e-05 | 199 | 28 | 4 | M9782 | |
| Coexpression | GSE557_CIITA_KO_VS_I_AB_KO_DC_DN | 5.83e-05 | 200 | 28 | 4 | M6014 | |
| Coexpression | BILD_MYC_ONCOGENIC_SIGNATURE | 6.92e-05 | 209 | 28 | 4 | M2069 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | 9.53e-05 | 721 | 28 | 6 | M1999 | |
| Coexpression | DARWICHE_PAPILLOMA_PROGRESSION_RISK | 1.29e-04 | 92 | 28 | 3 | MM503 | |
| Coexpression | KIM_MYCN_AMPLIFICATION_TARGETS_UP | 1.33e-04 | 93 | 28 | 3 | M18532 | |
| Coexpression | KRAS.600_UP.V1_UP | 2.10e-04 | 279 | 28 | 4 | M2882 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.93e-05 | 139 | 28 | 3 | 9e9f29f92dbe65b26cc78b3a1c00778c6a701f5b | |
| ToppCell | facs-Lung-3m-Hematologic-Lymphocytic_NK_ILC|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-04 | 150 | 28 | 3 | 1f83e3be3f94aefe991a3ccd292c2d11ddef858e | |
| ToppCell | facs-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-04 | 150 | 28 | 3 | cd666db614bc1b43d71e8eb7bf38cae4d580be80 | |
| ToppCell | facs-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-04 | 150 | 28 | 3 | f6ed3e7b36014d1e429b255b0027d89865e1ac07 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 154 | 28 | 3 | 75eac6970259a6916fcfa6d3400509cfa2d98d9d | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 157 | 28 | 3 | b337937a88f62030114a28d70a63168417672767 | |
| ToppCell | Severe-Lymphoid-NK-Proliferating_T|Severe / Condition, Lineage, Cell class and cell subclass | 1.35e-04 | 160 | 28 | 3 | cb2276d9bd78508644420e9580d3c17b914224cb | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.35e-04 | 160 | 28 | 3 | 19105debef96ea0c267d6a1d332303ec668ae47e | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 161 | 28 | 3 | 249c2b97cc25de5053f5048ee354615df49b2081 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-CD45____NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 162 | 28 | 3 | 04a96442e0fcdb6a65b9e45044021677f9f53d38 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 162 | 28 | 3 | 7adb3e279526e1f21033c10af0a0058258f21842 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 162 | 28 | 3 | 4b490989005bb03d4e7bbea01580f8548eff150f | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 162 | 28 | 3 | e4a09bf1a51710f6c57e6e01edf8b4619459d96d | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 163 | 28 | 3 | a0315855c354e830e109d41bd6e3396488aa8de9 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 164 | 28 | 3 | a59078c8f88e416e940c9b15151ce7de1bbe987e | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.46e-04 | 164 | 28 | 3 | 3caf4cdaa0164907893fea61e251fd8b5fa926e4 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 165 | 28 | 3 | 93ed399b8c6278e5f1528c07758fb502d80a1a8b | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 165 | 28 | 3 | 80f82aaab48791cb06fcb2d8ed7821f162742385 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.48e-04 | 165 | 28 | 3 | f6887c64af0f26e33316bc5587487e24d76ece2a | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 165 | 28 | 3 | 8741df8066a44c841752a99ad306d26ea68f5344 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 166 | 28 | 3 | 325ece9d7dad2b92eeb4defa109853660ac133ca | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 166 | 28 | 3 | 3213466380becf0ee3d4d9a0776ccbb1ee4eccea | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 166 | 28 | 3 | be45610f2fe606c328f5688189be40df5e678557 | |
| ToppCell | droplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.54e-04 | 167 | 28 | 3 | cde82e3dacf347226a78873b166608b7851b34d4 | |
| ToppCell | droplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.54e-04 | 167 | 28 | 3 | 6f54a699d9266c5f09ed890a11b403a6c8476fc1 | |
| ToppCell | droplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.54e-04 | 167 | 28 | 3 | 895844a45721988788d01120eb880603ba3ca139 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 167 | 28 | 3 | 02c89069dcd0e87f7502e32b14e7cbd3cab81a09 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 168 | 28 | 3 | 74dc46738f1d0a448df6c9b8288b515d92697792 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.56e-04 | 168 | 28 | 3 | dae37b316ce80dfe4236c4ed7f0d4e7c340fa7b6 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-04 | 168 | 28 | 3 | 08f6e171a1ea5cf65149744296d0fcd6c7b9684e | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.56e-04 | 168 | 28 | 3 | a74c8a9e3299183fba31ce3053ef325b5dbcd104 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.62e-04 | 170 | 28 | 3 | 0f215911b5880eeffeb43230f7eeaf55b612eaf2 | |
| ToppCell | droplet-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.65e-04 | 171 | 28 | 3 | 834b39b48bf3135dc41e787f5e20ebb234b5d97a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-04 | 172 | 28 | 3 | c056d44e2e130ceccadfcdceb192a7f095d779c8 | |
| ToppCell | droplet-Lung-3m-Hematologic-Lymphocytic_NK_ILC|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.68e-04 | 172 | 28 | 3 | a749f4ab4048d806a83f1f71a197584b8db833ad | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-04 | 173 | 28 | 3 | 789ab8b2709f4b8728e3733bc72744e9d92ea5ea | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-04 | 175 | 28 | 3 | 9d082ba0e350162aa6e71b668be074b12a27c7ab | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-04 | 175 | 28 | 3 | f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69 | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.76e-04 | 175 | 28 | 3 | 84d252f3e432231687613299bbea14978bb4b06b | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-04 | 175 | 28 | 3 | f641f34b52aec5d047430a6f9d026e915da6c11d | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.76e-04 | 175 | 28 | 3 | a00c6fa9b33640710dd05a3799031147196f0986 | |
| ToppCell | P28-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.82e-04 | 177 | 28 | 3 | e96a7e4544710aaab8bd2800ecff9667880a8bf4 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-mature_NK_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 177 | 28 | 3 | 52402ff6299210c46fd9dee3cef203c0eda7a98a | |
| ToppCell | P28-Endothelial-lymphatic_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.82e-04 | 177 | 28 | 3 | 6e330aa3c87fd640526b746a9deb3b2250d2518c | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.82e-04 | 177 | 28 | 3 | 59cf56c385c324f0844f20003d2b5049a2791e45 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-04 | 177 | 28 | 3 | dfaed388926ce050730492a532824af68bf4feff | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 177 | 28 | 3 | 9b02fd91c110b405eba6cb74ceb90b1286535973 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 179 | 28 | 3 | 69a1b3b05c921de6343ffe6ad998aa2b804312a7 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 179 | 28 | 3 | 479116ac65488c60104a053530830763ec1f95b2 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 179 | 28 | 3 | 1dfc0cb8b369aef35c59f3d4c52603dc9f3728c1 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.89e-04 | 179 | 28 | 3 | ca70a5518c5a5392e088c103e0cb44aa084f5332 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.89e-04 | 179 | 28 | 3 | c451b074b04eb5d6c575c6abaedda579c6744bbf | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.95e-04 | 181 | 28 | 3 | b244ecaa442bbef51289d8ec574ef08fa9e96318 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.95e-04 | 181 | 28 | 3 | dd79de8098edb385a0f85d0e9621503cdf76ec43 | |
| ToppCell | cellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.98e-04 | 182 | 28 | 3 | 8ccffcbae28c374fd4161fb0d4cf2c49fae557f6 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-04 | 183 | 28 | 3 | 547b1fb9f9940cfc8d6e351d96acc0da44def57e | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-04 | 183 | 28 | 3 | a90ffd9c50caa65f537a2e441e37655e1b622327 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-04 | 183 | 28 | 3 | 13ad20ec140ef5b96fdace3369b5befc0f40bb76 | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.04e-04 | 184 | 28 | 3 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | droplet-Marrow-nan-21m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 184 | 28 | 3 | 7e129862f8d2353387999e633725325c4d8cb42e | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.08e-04 | 185 | 28 | 3 | 59acaf025353405948dc34ccccf37ec5c08ea903 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 185 | 28 | 3 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.11e-04 | 186 | 28 | 3 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.14e-04 | 187 | 28 | 3 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | Fetal_29-31_weeks-Immune-natural_killer_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.18e-04 | 188 | 28 | 3 | 6686dbba990066568aa7573e70a7db8b4758f457 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.18e-04 | 188 | 28 | 3 | c2febf9fd4632af1f922067c3a30e5c50f75f480 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.25e-04 | 190 | 28 | 3 | b2bd2cb384bb8a5662064ed1aee68e905e1f780d | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.25e-04 | 190 | 28 | 3 | 32400c62cb9de4c2b24af4206c21a0215ab12212 | |
| ToppCell | Control-Lymphoid-ILC_A|Control / Disease state, Lineage and Cell class | 2.28e-04 | 191 | 28 | 3 | 1ca73582dc3d28322b5ee841010067589d848acc | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.32e-04 | 192 | 28 | 3 | a06d5d3c2537f8d2b1dc6b6f3e88a80b5c2a1850 | |
| ToppCell | human_hepatoblastoma-NK.T_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.39e-04 | 194 | 28 | 3 | 997b02a22d7c89a8fd5615bb79a2a8a34fc3fee6 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.42e-04 | 195 | 28 | 3 | 36d4a11bc77a4cc97a22525c78ef8359f4a3ca66 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.42e-04 | 195 | 28 | 3 | 98dd3b7d5ef587825dac052dea4d4ff883f6d4d6 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.42e-04 | 195 | 28 | 3 | ffb40486f8097b2c08e8f3b3685d0b8cb8d1bc66 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.42e-04 | 195 | 28 | 3 | b8124e8a23e6d37b40023608674e67285c6ffe84 | |
| ToppCell | distal-3-Endothelial-Lymphatic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.50e-04 | 197 | 28 | 3 | 9ea0e2ed9c3f97591a06e70570640996580417d5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.50e-04 | 197 | 28 | 3 | 54fb207638e211f8efdb13003ae62a6b1f003b09 | |
| ToppCell | distal-Endothelial-Lymphatic-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.50e-04 | 197 | 28 | 3 | 8f2e19409ebe9a490d5a245fa82c765ed6d77c3e | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.57e-04 | 199 | 28 | 3 | 1587d24b19f5bb64a3b6cc1df87c7c472cf41672 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.57e-04 | 199 | 28 | 3 | a9c2041e54899cb8ccc026758647f3ae3ca457dd | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_lymphatic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-04 | 200 | 28 | 3 | 76e90231aa94afc12e618da8ae314c51644acab4 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-KLHDC8A|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.61e-04 | 200 | 28 | 3 | 05bcde6ce8f1354ef65e4eb9cbd963a92108081c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Macroglial-Glia_progenitor_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.61e-04 | 200 | 28 | 3 | 6c1b7b0f3cd35d8cfee181ea83c73127dbc41ac5 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-04 | 200 | 28 | 3 | e3e80cb16e0d2e24efc16b62316a6da91bf81ea5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-KLHDC8A-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.61e-04 | 200 | 28 | 3 | 1a04331862079092bc04b1010aa9228c0fa3d8c5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-KLHDC8A--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.61e-04 | 200 | 28 | 3 | fb56d430957e73fba17db7bc0127ecf3577e0867 | |
| Computational | Genes in the cancer module 4. | 4.86e-04 | 21 | 17 | 2 | MODULE_4 | |
| Computational | Genes in the cancer module 233. | 5.34e-04 | 22 | 17 | 2 | MODULE_233 | |
| Computational | Genes in the cancer module 82. | 6.37e-04 | 24 | 17 | 2 | MODULE_82 | |
| Computational | Proteasome. | 1.52e-03 | 37 | 17 | 2 | MODULE_91 | |
| Drug | vanadyl | 2.73e-05 | 307 | 27 | 5 | CID000061671 | |
| Drug | GF109203X | 4.51e-05 | 341 | 27 | 5 | CID000002396 | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; HL60; HT_HG-U133A | 7.54e-05 | 193 | 27 | 4 | 1341_UP | |
| Drug | Fluorocurarine chloride [22273-09-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 8.16e-05 | 197 | 27 | 4 | 6219_UP | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; PC3; HT_HG-U133A | 8.49e-05 | 199 | 27 | 4 | 7384_UP | |
| Drug | Levocabastine hydrochloride [79547-78-7]; Down 200; 8.8uM; HL60; HT_HG-U133A | 8.65e-05 | 200 | 27 | 4 | 2948_DN | |
| Drug | N-methyl-DL-aspartic acid | 9.79e-05 | 655 | 27 | 6 | CID000004376 | |
| Drug | Pkcs | 1.06e-04 | 211 | 27 | 4 | CID000164073 | |
| Drug | K00077 | 1.25e-04 | 220 | 27 | 4 | CID006419759 | |
| Drug | acetyl-L-carnitine | 1.33e-04 | 84 | 27 | 3 | CID000000001 | |
| Drug | AC1L1G9T | 1.39e-04 | 433 | 27 | 5 | CID000003591 | |
| Drug | RK-1409B | 1.41e-04 | 15 | 27 | 2 | CID003036125 | |
| Drug | dansyl-DAG | 1.41e-04 | 15 | 27 | 2 | CID000129493 | |
| Drug | 1-stearoyl-2-arachidonylglycerol | 1.41e-04 | 15 | 27 | 2 | CID006443869 | |
| Drug | daphnoretin | 1.82e-04 | 17 | 27 | 2 | CID005281406 | |
| Drug | AC1L1JQC | 1.82e-04 | 17 | 27 | 2 | CID000005157 | |
| Drug | dihydrosterculic acid | 2.05e-04 | 18 | 27 | 2 | CID000160788 | |
| Drug | casticin | 2.10e-04 | 252 | 27 | 4 | ctd:C054133 | |
| Drug | TAPP-Br | 2.29e-04 | 19 | 27 | 2 | CID000160326 | |
| Drug | palmitoylcarnitine | 2.36e-04 | 102 | 27 | 3 | CID000000461 | |
| Drug | PX-866 | 2.54e-04 | 20 | 27 | 2 | CID009849735 | |
| Drug | KS-619-1 | 2.80e-04 | 21 | 27 | 2 | CID000128369 | |
| Drug | K-259-2 | 2.80e-04 | 21 | 27 | 2 | CID006438946 | |
| Drug | broussochalcone A | 2.80e-04 | 21 | 27 | 2 | CID006438825 | |
| Drug | AC1L1DXE | 4.03e-04 | 299 | 27 | 4 | CID000002548 | |
| Drug | bupivacaine | 4.29e-04 | 125 | 27 | 3 | CID000002474 | |
| Drug | AC1L1DKK | 4.50e-04 | 127 | 27 | 3 | CID000002390 | |
| Drug | pseudohypericin | 4.67e-04 | 27 | 27 | 2 | CID005281751 | |
| Drug | aplysiatoxin | 5.02e-04 | 28 | 27 | 2 | CID000040465 | |
| Drug | AMP group | 5.31e-04 | 579 | 27 | 5 | CID000000224 | |
| Drug | Polychlorinated biphenyls | 5.39e-04 | 29 | 27 | 2 | CID000006636 | |
| Drug | 1-alpha-25-dihydroxycholecalciferol | 5.74e-04 | 909 | 27 | 6 | CID000002524 | |
| Drug | IN1434 | 6.17e-04 | 31 | 27 | 2 | CID000002059 | |
| Drug | 9,11-octadecadienoic acid | 6.23e-04 | 142 | 27 | 3 | CID000074607 | |
| Drug | Zlllal | 6.87e-04 | 613 | 27 | 5 | CID000107707 | |
| Drug | AC1L1FGW | 6.99e-04 | 33 | 27 | 2 | CID000003231 | |
| Drug | barium | 7.02e-04 | 148 | 27 | 3 | CID000104810 | |
| Drug | chelerythrine | 7.84e-04 | 357 | 27 | 4 | CID000002703 | |
| Drug | norathyriol | 8.79e-04 | 37 | 27 | 2 | CID005281656 | |
| Drug | benzene | 9.79e-04 | 166 | 27 | 3 | CID000000241 | |
| Drug | AC1L1KEH | 1.03e-03 | 40 | 27 | 2 | CID000005462 | |
| Drug | digoxigenine | 1.03e-03 | 40 | 27 | 2 | CID000015478 | |
| Drug | lavendustin A | 1.07e-03 | 171 | 27 | 3 | CID000003894 | |
| Drug | antibiotic from Streptomyces | 1.13e-03 | 42 | 27 | 2 | CID000005153 | |
| Drug | benzenesulfonate | 1.13e-03 | 42 | 27 | 2 | CID000007371 | |
| Drug | carbachol | 1.15e-03 | 688 | 27 | 5 | CID000002551 | |
| Disease | azoospermia (implicated_via_orthology) | 2.79e-04 | 27 | 27 | 2 | DOID:14227 (implicated_via_orthology) | |
| Disease | Gastric Adenocarcinoma | 7.79e-04 | 45 | 27 | 2 | C0278701 | |
| Disease | IGFBP-3 measurement | 1.12e-03 | 54 | 27 | 2 | EFO_0004626 | |
| Disease | growth-regulated alpha protein measurement | 1.16e-03 | 55 | 27 | 2 | EFO_0008146 | |
| Disease | type 1 diabetes mellitus | 1.38e-03 | 242 | 27 | 3 | MONDO_0005147 | |
| Disease | Major Depressive Disorder | 1.39e-03 | 243 | 27 | 3 | C1269683 | |
| Disease | Unipolar Depression | 1.67e-03 | 259 | 27 | 3 | C0041696 | |
| Disease | intellectual disability (implicated_via_orthology) | 2.15e-03 | 75 | 27 | 2 | DOID:1059 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | 2.25e-03 | 616 | 27 | 4 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.25e-03 | 616 | 27 | 4 | C0376358 | |
| Disease | body surface area | 2.63e-03 | 643 | 27 | 4 | EFO_0022196 | |
| Disease | household income | 2.64e-03 | 304 | 27 | 3 | EFO_0009695 | |
| Disease | atrial fibrillation | 4.61e-03 | 371 | 27 | 3 | EFO_0000275 | |
| Disease | Malignant Neoplasms | 6.10e-03 | 128 | 27 | 2 | C0006826 | |
| Disease | venous thromboembolism | 8.34e-03 | 460 | 27 | 3 | EFO_0004286 | |
| Disease | rheumatoid arthritis | 8.44e-03 | 462 | 27 | 3 | EFO_0000685 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 8.50e-03 | 152 | 27 | 2 | DOID:0060041 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YLNIQSWPPHMHNFS | 396 | P21860 | |
| QLYHTEMDFPASAWN | 156 | Q8WW27 | |
| LPPTENWNFYMAFSF | 541 | Q6JQN1 | |
| SWQQPYPMDFYAGSS | 376 | Q9BZG8 | |
| MAYSWQTDPNPNESH | 1 | O75747 | |
| HWATDPDMYLQSPQS | 121 | Q9NQU5 | |
| FTFSDHYMDWVRQAP | 46 | A0A0B4J1Y9 | |
| TMYPPWDSTFDAHIN | 51 | Q04759 | |
| FGSYNNHAWSFPSEP | 191 | O76036 | |
| MAQHDFAPAWLNFPT | 1 | Q86WP2 | |
| VLDMYPEFSDHFWSS | 841 | Q12809 | |
| QFYHEDMPLWSSSTP | 506 | Q96RD9 | |
| RDPPYHNWMHAFSVS | 651 | O00408 | |
| IQNAAFMYPASPWSH | 761 | Q9BZL6 | |
| FYTPEAFNWRQAHMQ | 556 | Q9NY33 | |
| DWYMDFFPTPSNTTS | 646 | Q9H3R1 | |
| TWHLMDEFYFPQTTN | 1891 | P78509 | |
| YMNFSDPGPWSKVNH | 901 | Q6ZRK6 | |
| FTEAMTHFPASPFWS | 446 | Q9H2J7 | |
| THFPASPFWSVMFFL | 451 | Q9H2J7 | |
| APTFPSSNYFTAMWT | 176 | Q9NYY8 | |
| FHWQATIMGPNDSPY | 31 | P62837 | |
| MEESHFNSNPYFWPS | 1 | Q8TF68 | |
| FHWQATIMGPNDSPY | 31 | P61077 | |
| WYMDFFPVPSNASTD | 656 | P52849 | |
| HSRMAEPRFNNPYFW | 11 | Q5T0B9 | |
| FHWQATIMGPNDSPY | 31 | Q9Y2X8 | |
| DWPMFYHDFFTNILQ | 121 | Q96QU8 | |
| MPPDDDWRQSSYASH | 1636 | Q70EL1 |